{"name":"Evon Medics LLC","slug":"evon-medics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"COT","genericName":"COT","slug":"cot","indication":"Asthma","status":"marketed"}]}],"pipeline":[{"name":"COT","genericName":"COT","slug":"cot","phase":"marketed","mechanism":"COT is a corticosteroid that functions as an anti-inflammatory agent.","indications":["Asthma","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxQQm1vaVNVWjAzU2s5WFBFcDYxRVJJMFlUVklJOW5PWnZHd2RoRjVEa052RV9VRV85d3hCMXVNcThJUVdISVkwb2U0RmF4STBHNjh2cjRHLVZGX242RlU3UnBlbTZTczJpTXJjZWxoVkJ3bTR3R2UzZGlabGlsYlVrWFNudllTbEdiQWNhY3pWdlp3Mk1EMjlrLW9FWjRHNFpuRzI3a3M1cFJ3VTJfWGVQUW01ZmlJZmtsUG1CbHFlTDc3b2ZKYWRMYWk1V2VqVkZjM0tOMktLaFZubUgtcmRBcGhFWUxWU05WQ0RWeUZZc3BkV25rZHZ4YWRzYWh2N2hrQ0lPQ0cwWks3OEMxT0p3YWxMb2RoMWpMTWhYYndFOWhjamZLNnZldFN6VjBPSGs?oc=5","date":"2026-03-25","type":"trial","source":"PR Newswire","summary":"EvON Medics Data Demonstrates Digital Olfactory Therapy Reverses Gray Matter Loss in Key Alzheimer's Brain Regions and Significantly Improves Cognition - PR Newswire","headline":"EvON Medics Data Demonstrates Digital Olfactory Therapy Reverses Gray Matter Loss in Key Alzheimer's Brain Regions and S","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}